What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Internal medicine, Nuclear medicine, Endocrinology, Surgery and Radiation therapy.
His Internal medicine research includes themes of Positron emission tomography, Oncology and Cardiology.
His studies deal with areas such as Blood flow, Perfusion and Ventricular volume as well as Nuclear medicine.
He interconnects Receptor, Serotonin, Radioligand and Human brain in the investigation of issues within Endocrinology.
His Surgery research is multidisciplinary, incorporating perspectives in Gastroenterology and Lung cancer.
His research on Radiation therapy also deals with topics like
- Chemotherapy which connect with Toxicity,
- Survival rate and related Dose fractionation.
His most cited work include:
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer (1252 citations)
- Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. (1231 citations)
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide (1094 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Nuclear medicine, Radiology, Endocrinology and Oncology.
In general Internal medicine, his work in Radiation therapy and Lung cancer is often linked to In patient linking many areas of study.
His Radiation therapy study is focused on Surgery in general.
His research on Nuclear medicine frequently links to adjacent areas such as Blood flow.
Perfusion is the focus of his Radiology research.
His Endocrinology study frequently draws connections between adjacent fields such as Receptor.
He most often published in these fields:
- Internal medicine (29.43%)
- Nuclear medicine (22.07%)
- Radiology (10.10%)
What were the highlights of his more recent work (between 1998-2020)?
- Internal medicine (29.43%)
- Oncology (8.85%)
- Radiation therapy (7.36%)
In recent papers he was focusing on the following fields of study:
Henry N. Wagner focuses on Internal medicine, Oncology, Radiation therapy, Surgery and Lung cancer.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Radioimmunotherapy.
His Oncology study also includes fields such as
- Survival rate which connect with Dose fractionation,
- Carboplatin that intertwine with fields like Gemcitabine.
His research investigates the link between Radiation therapy and topics such as Etoposide that cross with problems in Small-cell carcinoma.
His research in Lung cancer intersects with topics in Respiratory disease, Radiology and Adjuvant therapy.
His Radiology study typically links adjacent topics like Nuclear medicine.
Between 1998 and 2020, his most popular works were:
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer (1252 citations)
- Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. (1231 citations)
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide (1094 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Henry N. Wagner mostly deals with Internal medicine, Radiation therapy, Oncology, Surgery and Lung cancer.
His work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology.
The study incorporates disciplines such as Etoposide, Chemotherapy, Performance status and Clinical trial in addition to Radiation therapy.
His Oncology research is multidisciplinary, incorporating elements of Stage, Radioimmunotherapy, Nuclear medicine and Hazard ratio.
His biological study spans a wide range of topics, including Respiratory disease, Primary tumor and Prophylactic cranial irradiation.
His Lung cancer study integrates concerns from other disciplines, such as Survival rate, Randomized controlled trial, Metastasis, Radiology and Adjuvant therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
